US FDA approves Gilead's drug for deadly liver infection

Food and Drug Administration ‌said on Friday it ‌approved Gilead Sciences' drug for a ​rare and deadly liver infection that ...
Tech Times

Eli Lilly’s Retatrutide Matches Bariatric Surgery: 30% Weight Loss in Phase 3 Trial

Eli Lilly on Thursday released results from TRIUMPH-1, its pivotal Phase 3 trial for the experimental obesity drug ...

Trump’s pick for surgeon general sells supplement with ingredient banned by Pentagon

Amazon opens an inquiry into Nicole Saphier’s product compliance following Guardian inquiry. White House says she will be a ‘powerful asset’ for Maha agenda ...

Gilead's drug wins first-ever US approval for deadly liver infection

The U.S. Food and ​Drug Administration said on ‌Friday it approved Gilead Sciences' drug for a rare and ​deadly liver ...
Medscape

Could Gene Editing Eventually Offer a ‘One-Time’ Treatment for CVD?

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

Human‑made chemicals are harming seals at the molecular level, study finds

Ringed seals are among the most common marine mammals in the Canadian Arctic. They strongly rely on sea ice as a habitat, ...
The Tech Edvocate

20 Surprising Foods High in Vitamin A That You Need in Your Diet

Spread the loveVitamin A is a crucial nutrient that plays a significant role in maintaining various bodily functions, from supporting vision to boosting the immune system. Unfortunately, many people ...
The Manila Times

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 - - Builds on completed Phase 1a study and ongoing development in HDV - S ...